The Future of Drug Discovery

Empowering the Next Generation of Drug Discovery

Modern AI and computational tools have democratized drug discovery. VivaMed is building the ecosystem that empowers citizen scientists, connects them with world-class data, and bridges the gap to pharmaceutical partners.

Our Vision

We envision a world where anyone with a promising drug discovery idea — regardless of credentials, location, or resources — has a clear path to bring it to patients. VivaMed is the ecosystem that makes this possible.

For Inventors

Citizen scientists, AI researchers, and small biotech firms finally have a path to bring their computational drug discoveries to market — with fair compensation and IP protection.

For Researchers

BioAtlas provides the most comprehensive biomedical knowledge base ever assembled — 490M+ rows integrating genetics, expression, drugs, and disease. Free and open.

For Pharma

Access a global network of computational innovators, license validated assets, post challenge problems, and accelerate your pipeline with AI-powered discovery.

The Problem

Citizen scientists have nowhere to turn. A brilliant researcher in Buenos Aires discovers a promising drug target using publicly available genomics data and open-source AI models. What happens next?

  • No access to pharmaceutical networks or licensing infrastructure
  • No capital for patents, validation studies, or regulatory expertise
  • No way to connect with CROs for experimental validation
  • Their breakthrough dies in a Jupyter notebook

Our Solution

VivaMed BioVentures creates the missing infrastructure: a platform where inventors submit ideas, we may handle patents and validation, CRO partners may run experiments, and pharma buyers may license the results — all subject to our Program Rules. The inventor may earn up to 10% of deal value — up to $1M per breakthrough. Most submissions do not result in payment.

Our Track Record

VivaMed BioPharma has been developing therapies for urgent, unmet needs for years

150+
Drug Assets
Licensed or Developed
39
Regulatory Approvals
Supported Globally
50+
Active Assets
In Current Pipeline
5
Countries
Across 3 Continents

The Ecosystem

Three pillars working together to accelerate drug discovery

🧬

BioAtlas

The world's most comprehensive biomedical knowledge base. 490M+ rows integrating genetics, expression, perturbations, drugs, and disease. Free and open on Hugging Face.

Explore BioAtlas
💡

BioVentures

The crowdsourcing platform for computational drug inventions. Submit ideas, get evaluation, and earn up to $1M when your invention leads to a successful deal.

Learn About BioVentures
🤝

Partner Network

CROs for validation, legal experts for IP, and pharmaceutical buyers for commercialization. We've built the network so inventors can focus on science.

Partner With Us

Ready to Change Medicine?

Whether you're an inventor with a breakthrough idea, a researcher seeking data, or a pharma company looking for innovation — there's a place for you.